Nexentis Technologies NXTS
NASDAQ NXTS
$1.69 +0.02 (+1.20%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nexentis Technologies (NXTS) Enterprise Value (2018 - 2026)

Nexentis Technologies (NXTS) posted Enterprise Value of -$5.5 million for Q2 2026, down 124.07% on a QoQ basis from -$2.4 million in Q4 2025, and down 103.39% year-over-year from $161.8 million in Q2 2025.

Analysis

Nexentis Technologies (NXTS) Enterprise Value (2018 - 2026) Analysis & Trends

Nexentis Technologies has reported Enterprise Value for 9 years, with the latest figure at -$5.5 million in Q2 2026.

  • On a quarterly basis, Enterprise Value fell 103.39% year-over-year to -$5.5 million in Q2 2026; TTM through Jun 2026 was -$5.5 million, a 103.39% decrease from a year earlier, with the FY2025 full-year figure at -$2.4 million, down 105.1% from the prior year.
  • Enterprise Value was -$5.5 million for Q2 2026 at Nexentis Technologies, down from -$2.4 million in the prior quarter.
  • The five-year high for Enterprise Value was $4.0 billion in Q1 2022, with the low at -$5.5 million in Q2 2026.
  • Average Enterprise Value over 5 years is $674.3 million, with a median of $145.5 million recorded in 2025.
  • The largest YoY upside for Enterprise Value was 209.25% in 2025 against a maximum downside of 106.31% in 2025.
  • Over 5 years, Enterprise Value stood at $641.2 million in 2022, then slumped by 87.6% to $79.5 million in 2023, then plunged by 39.7% to $48.0 million in 2024, then slumped by 105.1% to -$2.4 million in 2025, then slumped by 124.07% to -$5.5 million in 2026.
  • The last three Enterprise Value figures came in at -$5.5 million (Q2 2026), -$2.4 million (Q4 2025), and -$3.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Nexentis Technologies 1.40 Mn -7.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.49 Mn
Dec 31, 2025 -2.45 Mn
Sep 30, 2025 -3.03 Mn
Jun 30, 2025 161.83 Mn
Mar 31, 2025 145.45 Mn
Dec 31, 2024 47.96 Mn
Sep 30, 2024 48.02 Mn
Jun 30, 2024 52.33 Mn
Mar 31, 2024 131.35 Mn
Dec 31, 2023 79.54 Mn
Sep 30, 2023 178.68 Mn
Jun 30, 2023 1.12 Bn
Mar 31, 2023 771.38 Mn
Dec 31, 2022 641.23 Mn
Sep 30, 2022 1.72 Bn
Jun 30, 2022 2.38 Bn
Mar 31, 2022 4.00 Bn
Dec 31, 2021 2.75 Bn
Sep 30, 2021 4.38 Bn
Jun 30, 2021 4.18 Bn